Who
Frank Anders Wilson
Director
Company insider
Files Form 4 as: Director, Alkermes; Director, Cabot; Director, Novanta; Director, Sparton; Please See Remarks, Revvity.
In numbers
- Trades disclosed
- 150
- Buys
- 4
- Sells
- 6
- Bought
- $41K
- Sold
- $16.7M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 18 May 2009
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code F | $55K1,475 at $36.95 | filing |
| 21 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —6,142 | filing |
| 21 May 2026filed 22 May 2026 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code F | $55K1,475 at $36.95 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,538 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —11,538 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,409 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,409 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | CBT CabotChemicals | SEC FORM 4 Code A | —2,298 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | CBT CabotChemicals | SEC FORM 4 Code A | —2,298 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT NovantaElectronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —1,799 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT Novantaoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —1,799 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | NOVT NovantaElectronic Components & EMS | SEC FORM 4 Code M | —1,325 | filing |
| 31 May 2025filed 2 Jun 2025 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,013 | filing |
| 31 May 2025filed 2 Jun 2025 | ALKS AlkermesPharmaceuticals | SEC FORM 4 Code M | —8,013 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Frank Anders Wilson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.